- Home
- IOBT vs ALUR Comparison
IOBT vs ALUR Comparison
Compare IOBT & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- ALUR
- Stock Information
- Founded
- IOBT 2014
- ALUR 2009
- Country
- IOBT Denmark
- ALUR United States
- Employees
- IOBT N/A
- ALUR N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- IOBT Health Care
- ALUR
- Exchange
- IOBT Nasdaq
- ALUR Nasdaq
- Market Cap
- IOBT 77.7M
- ALUR 50.2M
- IPO Year
- IOBT 2021
- ALUR N/A
- Fundamental
- Price
- IOBT $0.84
- ALUR $0.60
- Analyst Decision
- IOBT Strong Buy
- ALUR Strong Buy
- Analyst Count
- IOBT 3
- ALUR 3
- Target Price
- IOBT $8.67
- ALUR $3.17
- AVG Volume (30 Days)
- IOBT 301.4K
- ALUR 264.8K
- Earning Date
- IOBT 08-13-2024
- ALUR 08-13-2024
- Dividend Yield
- IOBT N/A
- ALUR N/A
- EPS Growth
- IOBT N/A
- ALUR N/A
- EPS
- IOBT N/A
- ALUR N/A
- Revenue
- IOBT N/A
- ALUR $47,588,000.00
- Revenue This Year
- IOBT N/A
- ALUR N/A
- Revenue Next Year
- IOBT N/A
- ALUR $35.55
- P/E Ratio
- IOBT N/A
- ALUR N/A
- Revenue Growth
- IOBT N/A
- ALUR N/A
- 52 Week Low
- IOBT $0.80
- ALUR $0.56
- 52 Week High
- IOBT $2.10
- ALUR $6.43
- Technical
- Relative Strength Index (RSI)
- IOBT 27.78
- ALUR 36.25
- Support Level
- IOBT $1.53
- ALUR $0.62
- Resistance Level
- IOBT $1.62
- ALUR $0.85
- Average True Range (ATR)
- IOBT 0.11
- ALUR 0.10
- MACD
- IOBT -0.09
- ALUR 0.01
- Stochastic Oscillator
- IOBT 5.06
- ALUR 11.68
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.